Nonanimal Models for Acute Toxicity Evaluations: Applying Data-Driven Profiling and Read-Across.


Journal

Environmental health perspectives
ISSN: 1552-9924
Titre abrégé: Environ Health Perspect
Pays: United States
ID NLM: 0330411

Informations de publication

Date de publication:
04 2019
Historique:
entrez: 2 4 2019
pubmed: 2 4 2019
medline: 1 1 2020
Statut: ppublish

Résumé

Low-cost, high-throughput in vitro bioassays have potential as alternatives to animal models for toxicity testing. However, incorporating in vitro bioassays into chemical toxicity evaluations such as read-across requires significant data curation and analysis based on knowledge of relevant toxicity mechanisms, lowering the enthusiasm of using the massive amount of unstructured public data. We aimed to develop a computational method to automatically extract useful bioassay data from a public repository (i.e., PubChem) and assess its ability to predict animal toxicity using a novel bioprofile-based read-across approach. A training database containing 7,385 compounds with diverse rat acute oral toxicity data was searched against PubChem to establish in vitro bioprofiles. Using a novel subspace clustering algorithm, bioassay groups that may inform on relevant toxicity mechanisms underlying acute oral toxicity were identified. These bioassays groups were used to predict animal acute oral toxicity using read-across through a cross-validation process. Finally, an external test set of over 600 new compounds was used to validate the resulting model predictivity. Several bioassay clusters showed high predictivity for acute oral toxicity (positive prediction rates range from 62-100%) through cross-validation. After incorporating individual clusters into an ensemble model, chemical toxicants in the external test set were evaluated for putative acute toxicity (positive prediction rate equal to 76%). Additionally, chemical fragment -in vitro-in vivo relationships were identified to illustrate new animal toxicity mechanisms. The in vitro bioassay data-driven profiling strategy developed in this study meets the urgent needs of computational toxicology in the current big data era and can be extended to develop predictive models for other complex toxicity end points. https://doi.org/10.1289/EHP3614.

Sections du résumé

BACKGROUND
Low-cost, high-throughput in vitro bioassays have potential as alternatives to animal models for toxicity testing. However, incorporating in vitro bioassays into chemical toxicity evaluations such as read-across requires significant data curation and analysis based on knowledge of relevant toxicity mechanisms, lowering the enthusiasm of using the massive amount of unstructured public data.
OBJECTIVE
We aimed to develop a computational method to automatically extract useful bioassay data from a public repository (i.e., PubChem) and assess its ability to predict animal toxicity using a novel bioprofile-based read-across approach.
METHODS
A training database containing 7,385 compounds with diverse rat acute oral toxicity data was searched against PubChem to establish in vitro bioprofiles. Using a novel subspace clustering algorithm, bioassay groups that may inform on relevant toxicity mechanisms underlying acute oral toxicity were identified. These bioassays groups were used to predict animal acute oral toxicity using read-across through a cross-validation process. Finally, an external test set of over 600 new compounds was used to validate the resulting model predictivity.
RESULTS
Several bioassay clusters showed high predictivity for acute oral toxicity (positive prediction rates range from 62-100%) through cross-validation. After incorporating individual clusters into an ensemble model, chemical toxicants in the external test set were evaluated for putative acute toxicity (positive prediction rate equal to 76%). Additionally, chemical fragment -in vitro-in vivo relationships were identified to illustrate new animal toxicity mechanisms.
CONCLUSIONS
The in vitro bioassay data-driven profiling strategy developed in this study meets the urgent needs of computational toxicology in the current big data era and can be extended to develop predictive models for other complex toxicity end points. https://doi.org/10.1289/EHP3614.

Identifiants

pubmed: 30933541
doi: 10.1289/EHP3614
pmc: PMC6785238
doi:

Substances chimiques

Hazardous Substances 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

47001

Subventions

Organisme : NIEHS NIH HHS
ID : HHSN273201500010C
Pays : United States
Organisme : NIEHS NIH HHS
ID : R15 ES023148
Pays : United States

Références

J Med Chem. 2004 Dec 2;47(25):6239-47
pubmed: 15566294
Environ Health Perspect. 2011 Mar;119(3):364-70
pubmed: 20980217
J Med Chem. 2009 Jul 9;52(13):3829-45
pubmed: 19309080
Environ Health Perspect. 2016 May;124(5):634-41
pubmed: 26383846
J Steroid Biochem Mol Biol. 2013 Sep;137:242-70
pubmed: 23727548
Chem Res Toxicol. 2013 Aug 19;26(8):1199-208
pubmed: 23848138
J Chem Inf Model. 2006 Jul-Aug;46(4):1535
pubmed: 16859285
Chem Res Toxicol. 2014 Oct 20;27(10):1643-51
pubmed: 25195622
Toxicol In Vitro. 2009 Dec;23(8):1535-40
pubmed: 19591916
Toxicol Sci. 2015 Nov;148(1):137-54
pubmed: 26272952
Reprod Toxicol. 2010 Aug;30(1):147-60
pubmed: 20006701
ALTEX. 2015;32(1):25-40
pubmed: 25413849
Toxicol In Vitro. 1999 Aug-Oct;13(4-5):657-63
pubmed: 20654531
Regul Toxicol Pharmacol. 2018 Apr;94:183-196
pubmed: 29408321
Development. 1999 Jun;126(14):3205-16
pubmed: 10375510
J Chem Inf Model. 2015 Mar 23;55(3):510-28
pubmed: 25647539
Crit Rev Toxicol. 2012 Sep;42(8):633-52
pubmed: 22667820
Bioinformatics. 2017 Feb 1;33(3):464-466
pubmed: 28172359
PLoS One. 2014 Jun 20;9(6):e99863
pubmed: 24950175
Molecules. 2017 Dec 05;22(12):null
pubmed: 29206216
Toxicol Sci. 2015 Oct;147(2):386-96
pubmed: 26139166
J Med Chem. 2010 Nov 11;53(21):7632-8
pubmed: 20931970
Oncol Rep. 2007 Sep;18(3):695-701
pubmed: 17671722
J Comput Aided Mol Des. 2014 Jun;28(6):631-46
pubmed: 24840854
Pharm Res. 2014 Apr;31(4):1002-14
pubmed: 24306326
Environ Health Perspect. 2009 May;117(5):685-95
pubmed: 19479008
Chem Res Toxicol. 2009 Dec;22(12):1913-21
pubmed: 19845371
Cell Biol Toxicol. 1994 Jun;10(3):155-62
pubmed: 7994632
Regul Toxicol Pharmacol. 2008 Jun;51(1):108-18
pubmed: 18362045
Regul Toxicol Pharmacol. 2016 Dec;82:99-110
pubmed: 27765716
ALTEX. 2014;31(4):387-96
pubmed: 25368965
Bioorg Chem. 2017 Aug;73:128-146
pubmed: 28668650
Nucleic Acids Res. 2015 Jul 1;43(W1):W605-11
pubmed: 25934803
ALTEX. 2013;30(1):3-18
pubmed: 23338803
Nature. 1965 Dec 18;208(5016):1169-70
pubmed: 5870313
Nature. 2009 Aug 27;460(7259):1080-1
pubmed: 19713914
Ther Adv Med Oncol. 2010 Jul;2(4):237-50
pubmed: 21789137
Chem Res Toxicol. 2017 Apr 17;30(4):946-964
pubmed: 27933809
Pharm Res. 2015 Sep;32(9):3055-65
pubmed: 25862462
Toxicol In Vitro. 1994 Dec;8(6):1303-12
pubmed: 20693102
Environ Health Perspect. 1998 Apr;106 Suppl 2:497-503
pubmed: 9599698
Toxicol In Vitro. 2013 Jun;27(4):1347-56
pubmed: 22951948
ALTEX. 2016;33(2):167-82
pubmed: 26863516
Environ Sci Technol. 2015 Jul 21;49(14):8804-14
pubmed: 26066997
Sci Rep. 2017 Feb 07;7:41574
pubmed: 28169282
J Exp Clin Cancer Res. 2014 Nov 25;33:93
pubmed: 25422081
Free Radic Biol Med. 2007 Jun 15;42(12):1797-806
pubmed: 17512459
Chem Res Toxicol. 2008 Dec;21(12):2300-12
pubmed: 19053326
Chem Res Toxicol. 2008 Feb;21(2):513-20
pubmed: 18189367
Chem Res Toxicol. 2013 Dec 16;26(12):1840-61
pubmed: 24206190
ACS Omega. 2017 Jun 30;2(6):2805-2812
pubmed: 28691113
Drug Discov Today. 2013 Aug;18(15-16):716-23
pubmed: 23732176
PLoS One. 2012;7(6):e38996
pubmed: 22768056
J Chem Inf Model. 2010 May 24;50(5):742-54
pubmed: 20426451
Clin Cancer Res. 2005 Mar 15;11(6):2355-63
pubmed: 15788687
Regul Toxicol Pharmacol. 2012 Jun;63(1):10-9
pubmed: 22369873
ALTEX. 2016;33(2):83-93
pubmed: 27032088
Biochem J. 2003 Jan 1;369(Pt 1):1-15
pubmed: 12396231
Curr Opin Chem Biol. 2011 Feb;15(1):162-73
pubmed: 21195017
Free Radic Biol Med. 2004 May 15;36(10):1199-207
pubmed: 15110384
ALTEX. 2016;33(2):111-22
pubmed: 26863198
J Biochem Mol Toxicol. 2008 Feb;22(1):63-76
pubmed: 18273910
Mol Biol Cell. 2017 Feb 1;28(3):387-395
pubmed: 27932496
Chem Res Toxicol. 2014 Dec 15;27(12):2100-12
pubmed: 25354311
J Biol Chem. 2011 Oct 21;286(42):36171-9
pubmed: 21878643
Chem Res Toxicol. 2012 Dec 17;25(12):2763-9
pubmed: 23148656
Am J Hum Genet. 2000 Nov;67(5):1047-54
pubmed: 11001584
ALTEX. 2013;30(3):331-51
pubmed: 23861078
Comb Chem High Throughput Screen. 2010 Feb;13(2):188-206
pubmed: 20053163

Auteurs

Daniel P Russo (DP)

1 Center for Computational and Integrative Biology, Rutgers University , Camden, New Jersey, USA.

Judy Strickland (J)

2 Integrated Laboratory Systems (ILS) , Research Triangle Park, North Carolina, USA.

Agnes L Karmaus (AL)

2 Integrated Laboratory Systems (ILS) , Research Triangle Park, North Carolina, USA.

Wenyi Wang (W)

1 Center for Computational and Integrative Biology, Rutgers University , Camden, New Jersey, USA.

Sunil Shende (S)

1 Center for Computational and Integrative Biology, Rutgers University , Camden, New Jersey, USA.
3 Department of Computer Science, Rutgers University , Camden, New Jersey, USA.

Thomas Hartung (T)

4 Johns Hopkins Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT) , Baltimore, Maryland, USA.
5 University of Konstanz, CAAT-Europe , Konstanz, Germany.

Lauren M Aleksunes (LM)

6 Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University , Piscataway, New Jersey, USA.

Hao Zhu (H)

1 Center for Computational and Integrative Biology, Rutgers University , Camden, New Jersey, USA.
7 Department of Chemistry, Rutgers University , Camden, New Jersey, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH